BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31277366)

  • 1. Characterization of the Pathophysiological Role of CD47 in Uveal Melanoma.
    Petralia MC; Mazzon E; Fagone P; Russo A; Longo A; Avitabile T; Nicoletti F; Reibaldi M; Basile MS
    Molecules; 2019 Jul; 24(13):. PubMed ID: 31277366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential modulation and prognostic values of immune-escape genes in uveal melanoma.
    Basile MS; Mazzon E; Russo A; Mammana S; Longo A; Bonfiglio V; Fallico M; Caltabiano R; Fagone P; Nicoletti F; Avitabile T; Reibaldi M
    PLoS One; 2019; 14(1):e0210276. PubMed ID: 30653520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive Role of Immune System Infiltration and Angiogenesis in Uveal Melanoma Progression.
    García-Mulero S; Alonso MH; Del Carpio LP; Sanz-Pamplona R; Piulats JM
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
    Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
    Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic landscape of adaptive immune resistance signatures and infiltrating immune cells in the tumor microenvironment of uveal melanoma.
    Wang Y; Xu Y; Dai X; Lin X; Shan Y; Ye J
    Exp Eye Res; 2020 Jul; 196():108069. PubMed ID: 32439398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of survival-related genes and a novel gene-based prognostic signature involving the tumor microenvironment of uveal melanoma.
    Lei S; Zhang Y
    Int Immunopharmacol; 2021 Jul; 96():107816. PubMed ID: 34162166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.
    Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA
    Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment.
    Gezgin G; Dogrusöz M; van Essen TH; Kroes WGM; Luyten GPM; van der Velden PA; Walter V; Verdijk RM; van Hall T; van der Burg SH; Jager MJ
    Cancer Immunol Immunother; 2017 Jul; 66(7):903-912. PubMed ID: 28391358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development.
    Figueiredo CR; Kalirai H; Sacco JJ; Azevedo RA; Duckworth A; Slupsky JR; Coulson JM; Coupland SE
    J Pathol; 2020 Apr; 250(4):420-439. PubMed ID: 31960425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of molecular subtyping system and four-gene prognostic signature with immune-related genes for uveal melanoma.
    Xia F; Yu Z; Deng A; Gao G
    Exp Biol Med (Maywood); 2022 Feb; 247(3):246-262. PubMed ID: 34743576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma.
    Ewens KG; Kanetsky PA; Richards-Yutz J; Purrazzella J; Shields CL; Ganguly T; Ganguly A
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(8):5160-7. PubMed ID: 24970262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of allele-specific down-regulation of HLA class I expression in uveal melanoma cell lines.
    Hurks HM; Metzelaar-Blok JA; Mulder A; Claas FH; Jager MJ
    Int J Cancer; 2000 Mar; 85(5):697-702. PubMed ID: 10699951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embryonic Stem Cells Modulate the Cancer-Permissive Microenvironment of Human Uveal Melanoma.
    Liu J; Huang Z; Yang L; Wang X; Wang S; Li C; Liu Y; Cheng Y; Wang B; Sang X; He X; Wang C; Liu T; Liu C; Jin L; Liu C; Zhang X; Wang L; Wang Z
    Theranostics; 2019; 9(16):4764-4778. PubMed ID: 31367256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and immunohistochemical analyses of uveal melanoma patient cohort.
    Sarubi HC; Pereira NB; Gomes CC; Gomez RS; Carmo ACM; Melo FM; Bastos-Rodrigues L; Pedrosa MS; Friedman E; De Marco L
    Melanoma Res; 2019 Jun; 29(3):248-253. PubMed ID: 30480620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-Wide Analysis of Uveal Melanoma Metastasis-Associated LncRNAs and Their Functional Network.
    Xu B; Ma R; Ren H; Qian J
    DNA Cell Biol; 2018 Feb; 37(2):99-108. PubMed ID: 29240458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immune cell landscape of metastatic uveal melanoma correlates with overall survival.
    Tosi A; Cappellesso R; Dei Tos AP; Rossi V; Aliberti C; Pigozzo J; Fabozzi A; Sbaraglia M; Blandamura S; Del Bianco P; Chiarion-Sileni V; Rosato A
    J Exp Clin Cancer Res; 2021 May; 40(1):154. PubMed ID: 33947438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIC1 modulates uveal melanoma progression by activating lncRNA-numb.
    Cheng G; He J; Zhang L; Ge S; Zhang H; Fan X
    Tumour Biol; 2016 Sep; 37(9):12779-12789. PubMed ID: 27449031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAM10 correlates with uveal melanoma metastasis and promotes in vitro invasion.
    Gangemi R; Amaro A; Gino A; Barisione G; Fabbi M; Pfeffer U; Brizzolara A; Queirolo P; Salvi S; Boccardo S; Gualco M; Spagnolo F; Jager MJ; Mosci C; Rossello A; Ferrini S
    Pigment Cell Melanoma Res; 2014 Nov; 27(6):1138-48. PubMed ID: 25124714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digital PCR-Based T-cell Quantification-Assisted Deconvolution of the Microenvironment Reveals that Activated Macrophages Drive Tumor Inflammation in Uveal Melanoma.
    de Lange MJ; Nell RJ; Lalai RN; Versluis M; Jordanova ES; Luyten GPM; Jager MJ; van der Burg SH; Zoutman WH; van Hall T; van der Velden PA
    Mol Cancer Res; 2018 Dec; 16(12):1902-1911. PubMed ID: 30093564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Landscape of Infiltrated Immune Cell Characterization in Uveal Melanoma to Improve Immune Checkpoint Blockade Therapy.
    Lv X; Ding M; Liu Y
    Front Immunol; 2022; 13():848455. PubMed ID: 35309331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.